Bìa tạp chí

 

009bet

Optimization of spectrophotometric method for determination nattokinase activity in dietary supplements

Hoang Viet Dung Nguyen Thi Hong Ngoc Vu Thi Thanh An Mac Thi Thanh Hoa Cao Cong Khanh Tran Hung Son Nguyen Thi Dieu Thu
Received: 06 Apr 2020
Revised: 22 Jun 2020
Accepted: 22 Jun 2020
Published: 30 Jun 2020

Article Details

How to Cite
Hoang Viet Dung, Nguyen Thi Hong Ngoc, Vu Thi Thanh An, Mac Thi Thanh Hoa, Cao Cong Khanh, Tran Hung Son, Nguyen Thi Dieu Thu. "Optimization of spectrophotometric method for determination nattokinase activity in dietary supplements". Vietnam Journal of Food Control. vol. 3, no. 2 (en), pp. 96-103, 2020
PP
96-103
Counter
967

Main Article Content

Abstract

Nattokinase is an enzyme with a strong fibrinolytic activity that can be used for preventing thrombolytic diseases. The fibrinolytic activity of the Nattokinase in dietary supplements is determined by spectrophotometric method. In this study, the conditions of the assay were examined and finally optimized as pH: 8.5, reaction temperature: 40oC, and reaction time: 60 minutes. The proposed method was validated and successfully applied to determine the Nattokinase activity in 10 dietary supplements. The results showed that the proportion of measured activity compared to label product activity were within in the range 79.1 - 98.0%. The effect of herbal compounds and excipients on Nattokinase activity were also surveyed. From the evaluated results and application to commercial samples, this method will be a valuable contribution to quality control of dietary supplement products containing Nattokinase.

 

Keywords:

Nattokinase, dietary supplements, fibrinolytic activity, spectrophotometric method

References

[1] M. Tai and B. Sweet, “Nattokinase for prevention of thrombosis”, American Journal of Health System Pharmacy, vol. 63, no. 12, pp. 1121­1123, 2006.
[2] C. Devi, V. Mohanasrinivasan, P. Sharma, D. Das, B. Vaishnavi and S. Naine, “Production, Purification and Stability Studies on Nattokinase: A Therapeutic Protein Extracted from Mutant Pseudomonas aeruginosa CMSS Isolated from Bovine Milk”, International Journal of Peptide Research and Therapeutics, vol. 22, no. 2, pp. 263­269, 2015.
[3] E. Selvarajan and N. Bhatnagar, “Nattokinase: An updated critical review on challenges and perspectives”, Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 15, no. 2, pp. 128­135, 2018.
[4] P. Singh and R. Negi, “Production of fibrinolytic enzyme (nattokinase) from bacillus sp.”, Indo American journal of pharmaceutical sciences, vol. 05, no. 1, pp. 379­383, 2018.
[5] Y. Weng, J. Yao, S. Sparks and K. Wang, “Nattokinase: An oral antithrombotic agent for the prevention of cardiovascular disease”, International Journal of Molecular Sciences, vol.18, no.3, pp. 1­13, 2017.
[6] T. Astrup and S. Müllertz, “The fibrin plate method for estimating fibrinolytic activity”, Archives of Biochemistry and Biophysics, vol. 40, no. 2, pp. 346­351, 1952.
[7] X. Xin, “Investigations of the industrial compatible aqueous purification techniques an intrinsic stabilizing factors for nattokinase”, Open Access Theses and Dissertations, 2016.

 Submit